[1]Yamaoka,Nagahisa;Kodama,Hidehiko;Izuhara,Yuko;Miyata,Toshio;Meguro,Kanji[ChemicalandPharmaceuticalBulletin,2011,vol.59,#2,p.215-224]
[1]Yamaoka,Nagahisa;Kodama,Hidehiko;Izuhara,Yuko;Miyata,Toshio;Meguro,Kanji[ChemicalandPharmaceuticalBulletin,2011,vol.59,#2,p.215-224]
[1]Yamaoka,Nagahisa;Kodama,Hidehiko;Izuhara,Yuko;Miyata,Toshio;Meguro,Kanji[ChemicalandPharmaceuticalBulletin,2011,vol.59,#2,p.215-224]
[1]Locationinpatent:experimentalpartYamaoka,Nagahisa;Kodama,Hidehiko;Izuhara,Yuko;Miyata,Toshio;Meguro,Kanji[ChemicalandPharmaceuticalBulletin,2011,vol.59,#2,p.215-224]
Title: Izuhara Y, et al. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates. J Cereb Blood Flow Metab. 2010 May;30(5):904-12.
Title: Yasui H, et al. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells. Thromb Res. 2013 Jul;132(1):100-5.
Title: Mashiko S, et al. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer. Cancer Biol Ther. 2015;16(2):253-60.
